Hisamitsu Pharmaceutical Overview
- Year Founded
-
1847
- Status
-
Public
- Employees
-
3,682
- Stock Symbol
-
4530
- Investments
-
3
- Share Price
-
$27.29
- (As of Friday Closing)
Hisamitsu Pharmaceutical General Information
Description
Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.
Contact Information
Website
www.hisamitsu.co.jpCorporate Office
- 408 Tashiro Daikan-machi
- Tosu
- Saga, 841-0017
- Japan
Corporate Office
- 408 Tashiro Daikan-machi
- Tosu
- Saga, 841-0017
- Japan
Hisamitsu Pharmaceutical Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $27.29 | $26.95 | $22.83 - $35.69 | $2B | 73.3M | 134K | $1.31 |
Hisamitsu Pharmaceutical Financials Summary
|
In Thousands, USD |
TTM 31-May-2024 | FY 2024 29-Feb-2024 | FY 2023 28-Feb-2023 | FY 2022 28-Feb-2022 |
|---|---|---|---|---|
| EV | 999,508 | 1,130,133 | 1,134,761 | 1,296,011 |
| Revenue | 984,303 | 990,022 | 957,078 | 1,077,838 |
| EBITDA | 152,388 | 150,546 | 153,740 | |
| Net Income | 99,554 | 97,594 | 87,571 | 86,609 |
| Total Assets | 2,158,664 | 2,182,336 | 2,302,330 | 2,620,219 |
| Total Debt | 7,199 | 13,939 | 16,832 | 21,283 |
Hisamitsu Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hisamitsu Pharmaceutical Executive Team (2)
| Name | Title | Board Seat |
|---|---|---|
| Kazuhide Nakatomi | Chief Executive Officer, Board Member and President | |
| Nobuo Tsutsumi | Board Member & Executive |
Hisamitsu Pharmaceutical Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Hisamitsu Pharmaceutical | Chief Executive Officer, Board Member and President | ||
| Hisamitsu Pharmaceutical | Board Member & Executive | ||
| Self | Board Member |
Hisamitsu Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hisamitsu Pharmaceutical Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| AYUMI Pharmaceutical | 08-Mar-2022 | Pharmaceuticals | |||
| GAIA BioMedicine | 21-Sep-2021 | Drug Discovery | |||
| Noven Pharmaceuticals | 27-Aug-2009 | Merger/Acquisition | Pharmaceuticals |
Hisamitsu Pharmaceutical Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Noven Pharmaceuticals | Pharmaceuticals | Miami, FL |
Hisamitsu Pharmaceutical ESG
Risk Overview
Risk Rating
Updated May, 31, 2024
33.18 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 16,009
Rank
Percentile
Pharmaceuticals
Industry
of 909
Rank
Percentile
Pharmaceuticals
Subindustry
of 446
Rank
Percentile
Hisamitsu Pharmaceutical FAQs
-
When was Hisamitsu Pharmaceutical founded?
Hisamitsu Pharmaceutical was founded in 1847.
-
Who is the CEO of Hisamitsu Pharmaceutical?
Kazuhide Nakatomi is the CEO of Hisamitsu Pharmaceutical.
-
Where is Hisamitsu Pharmaceutical headquartered?
Hisamitsu Pharmaceutical is headquartered in Saga, Japan.
-
What is the size of Hisamitsu Pharmaceutical?
Hisamitsu Pharmaceutical has 3,682 total employees.
-
What industry is Hisamitsu Pharmaceutical in?
Hisamitsu Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Hisamitsu Pharmaceutical a private or public company?
Hisamitsu Pharmaceutical is a Public company.
-
What is Hisamitsu Pharmaceutical’s stock symbol?
The ticker symbol for Hisamitsu Pharmaceutical is 4530.
-
What is the current stock price of Hisamitsu Pharmaceutical?
As of 04-Oct-2024 the stock price of Hisamitsu Pharmaceutical is $27.29.
-
What is the current market cap of Hisamitsu Pharmaceutical?
The current market capitalization of Hisamitsu Pharmaceutical is $2B.
-
What is Hisamitsu Pharmaceutical’s current revenue?
The trailing twelve month revenue for Hisamitsu Pharmaceutical is $984M.
-
What is Hisamitsu Pharmaceutical’s annual earnings per share (EPS)?
Hisamitsu Pharmaceutical’s EPS for 12 months was $1.31.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
